Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
SFL Corp
SFL
$1.57B
| $13.9M | 0.01% |
956,397
+169,965
| +22% | +$2.46M |
|
1227
Accuray
ARAY
$32.9M
| $13.9M | 0.01% |
4,926,313
+35,804
| +0.7% | +$99.4K |
|
|
HMLP
1228
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $13.9M | 0.01% |
888,099
+131,800
| +17% | +$2.04M |
|
1229
National Presto Industries
NPK
$998M
| $13.9M | 0.01% |
156,900
+17,300
| +12% | +$1.51M |
|
1230
Energy Transfer Partners
ET
$71.5B
| $13.9M | 0.01% |
1,080,145
+105,767
| +11% | +$1.3M |
|
1231
Martin Marietta Materials
MLM
$32.7B
| $13.8M | 0.01% |
+49,470
| New | +$13.2M |
|
1232
Mizuho Financial
MFG
$134B
| $13.8M | 0.01% |
4,466,385
+208,785
| +5% | +$650K |
|
|
WUBA
1233
DELISTED
58.com Inc
WUBA
| $13.8M | 0.01% |
212,863
+54,000
| +34% | +$3.04M |
|
1234
Performance Food Group
PFGC
$16.9B
| $13.8M | 0.01% |
267,400
+147,100
| +122% | +$6.72M |
|
1235
Digi International
DGII
$3.23B
| $13.8M | 0.01% |
776,284
+3,400
| +0.4% | +$54K |
|
1236
Invesco Senior Loan ETF
BKLN
$6.76B
| $13.7M | 0.01% |
601,900
+568,554
| +1,705% | +$12.8M |
|
1237
Commercial Vehicle Group
CVGI
$130M
| $13.7M | 0.01% |
2,161,007
+23,207
| +1% | +$165K |
|
|
BOLD
1238
DELISTED
Audentes Therapeutics, Inc
BOLD
| $13.7M | 0.01% |
228,100
+149,400
| +190% | +$5.61M |
|
|
SHI
1239
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $13.6M | 0.01% |
446,648
+58,240
| +15% | +$1.66M |
|
|
VRTU
1240
DELISTED
Virtusa Corporation
VRTU
| $13.6M | 0.01% |
300,596
-29,500
| -9% | -$1.2M |
|
1241
Oppenheimer Holdings
OPY
$1.23B
| $13.6M | 0.01% |
495,300
+26,200
| +6% | +$730K |
|
1242
Heartland Express
HTLD
$979M
| $13.6M | 0.01% |
646,533
-71,700
| -10% | -$1.54M |
|
|
GLOG
1243
DELISTED
GASLOG LTD
GLOG
| $13.6M | 0.01% |
1,389,599
-6,401
| -0.5% | -$72.8K |
|
|
PCTI
1244
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $13.6M | 0.01% |
1,606,037
+39,304
| +3% | +$326K |
|
1245
iShares National Muni Bond ETF
MUB
$45.9B
| $13.6M | 0.01% |
119,100
+80,919
| +212% | +$9.22M |
|
|
NATI
1246
DELISTED
National Instruments Corp
NATI
| $13.6M | 0.01% |
+320,266
| New | +$13.4M |
|
1247
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $13.6M | 0.01% |
154,100
+69,500
| +82% | +$6.05M |
|
|
CHA
1248
DELISTED
China Telecom Corporation, LTD
CHA
| $13.5M | 0.01% |
328,900
+41,700
| +15% | +$1.75M |
|
1249
Mercer International
MERC
$33.8M
| $13.5M | 0.01% |
1,098,300
-172,841
| -14% | -$2.11M |
|
1250
Carlisle Companies
CSL
$15.2B
| $13.5M | 0.01% |
83,300
-159,400
| -66% | -$24.6M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.